BioNTech's Kigali plant: inaugurated in 2023, built for vaccines Africa has not had - but not yet a working factory story
BioNTech inaugurated its Kigali site in December 2023, built around container-like BioNTainer units, with about USD 150 million committed and room for up to 50 million doses a year of a COVID-like product. Its own plan put test production for validation in 2025 - commercial supply is a later step, and we found no confirmation it has begun.
5 verified· 0 disputed· 1 not yet verified· 0 corrected